Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide

By:

U.S. Department of Health and Human Services

Format:

Paperback / softback

Show Hide Adult Content

$52.00

Available from supplier

Usually ships in 3-4 weeks

0 in Trolley

Price Match

Free Delivery with Primate

Join Now

Free 14 day free trial, cancel anytime.

Buy Now, Pay Later with:

Afterpay is available on orders $100 to $2000 Learn more

6 weekly interest-free payments of $8.67 with Laybuy Learn more

Availability

Delivering to:

Estimated arrival:

Around 17-29 July using International Courier

Description

The profile of opioid misuse and opioid use disorder in the United States is changing, in that nonmedical use of prescription opioids has become as significant a problem as the use of heroin.1 Federal data for 2013 indicate that approximately 4.5 million people in the United States reported nonmedical use of prescription pain relievers in the past month and 289,000 reported use of heroin in the past month.2 Despite the dimensions of the problem, nearly 80 percent of people with an opioid use disorder do not receive treatment because of limited treatment capacity, financial obstacles, social bias, and other barriers to care. Researchers, federal health agencies, and pharmaceutical manufacturers have focused on developing medications that can be used to expand access to treatment of an opioid use disorder in medical office settings, rather than limiting use to specialized opioid treatment programs (OTPs).

Release date NZ

November 23rd, 2019

Author

U.S. Department of Health and Human Services

Audience

General (US: Trade)

Pages

ISBN-13

9781794764286

Product ID

32740044

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here